Study: HIV drug reduces graft-versus-host disease in stem cell transplant patients Westmoreland County Times An HIV drug that redirects immune cell traffic appears to significantly reduce the dangerous complication graft-versus-host disease (GvHD) in blood cancer patients following allogeneic stem cell transplantation (ASCT), according to new research from ... |
